GenScript is a leading global biotechnology partner dedicated to accelerating early-stage drug discovery and development. Serving top pharmaceutical and biotech companies worldwide, GenScript provides an integrated portfolio of customized life science services, encompassing gene synthesis, protein expression, reagent antibody, peptide synthesis, CRISPR solutions, mRNA manufacturing, etc.

For therapeutics teams in the Boston biotech hub, GenScript offers the specialized expertise and high-throughput scale required to rapidly advance antibody candidates from target validation to preclinical development. We understand that speed, yield, and manufacturability are critical to your pipeline's success.

A cornerstone of our antibody drug discovery capability is the proprietary TurboCHO™ Expression System. Designed to meet the complex demands of modern biologics, TurboCHO™ enables the rapid production of high-quality recombinant antibodies, delivering purified products from gene sequences in as few as 5 business days. Validated across over 200 complex bispecific formats and trusted by top-20 pharma, the platform seamlessly transitions from high-throughput microscale screening (1,000+ variants per day) to kilogram-level manufacturing. With exceptional titers up to 3 g/L and >95% purity, TurboCHO™ ensures highly consistent, scalable results.

Partner with GenScript to leverage our 20+ years of proven expertise, accelerating your lead generation and de-risking your path to the clinic.